Antibiotic Action Plan

Section 3 of the Promise for Antibiotics and Therapeutics for Health Act or the PATH Act, which call for current PATH Act legislation to be modified so that it “will allow health experts to more easily develop new treatments for antibiotic resistant bacteria, and make real progress in presenting a great number of illnesses and deaths in the United States”1. In addition, this new legislation will impact Section 506 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C 356) by introducing into its current language a new subsection (g) “Limited Population Pathway for Antibacterial Drugs”. Thus creating new avenues for the introduction of alternative treatments for limited populations based on the recommendation of Secretary

Antibiotics-resistant organisms have become one of the most serious threats to public health, infecting over two million people and killing approximately 23,000 people annually.1 According to the CDC, “total inappropriate antibiotic use,” such as prescribing unnecessary antibiotics or giving the wrong dose or duration, makes up to 50% of all outpatient antibiotic use,2,3 and in 2009, the United States spent $10.7 billion on antibiotics, indicating that there is a lot of potential money to save.4

The development and advancement of antibiotic resistance is dependent on a number of factors, and cannot be resolved with one single solution. Research suggests the best strategy to manage the misuse of antibiotics leading to antibiotic resistance, is mandating all hospitals to implement an antimicrobial stewardship program. This solution meets all of the required criteria and is a sensible approach in resolving the growing rate of resistant. Making antimicrobial stewardships a part of the patient safety effort will help bring new support and spark the conversation that must take place in order to make advancement in resolving antibiotic resistance. Multiple studies have been conducted to evaluate the before and after introduction of ASPs and

I think both the government and hospitals have the responsibility to tracking this dangerous health problem and everyone has right for supporting the research for the new drug. This way we will have a better way to deal with antibiotic resistant. We will have an organize data and reports to know where the resistance is occurring like they do in

Antimicrobial resistance is a growing, global problem (World health organisation [WHO], 2016) that has resulted in action from the Department of Health [DH], (2013). in the form of a five year Antimicrobial Resistance (AMR) Strategy. The AMR strategy running 2013-2018 aims to build international alliances with governments and partners across

However, the scene is changing dramatically once again, and not in our favor. Antibiotic resistant bacteria

Consequently within a decade, bacteria can get the upper hand and the only way to cure an infection will be radical surgery to eradicate the source of infection similar to the pre-antibiotics era. Frequent antibiotic use contributes to fastening the spread of antibiotic resistance gene due to selective pressure. To prevent increase of superbugs, controlling the antibiotic use by implying mandatory antimicrobial stewardship programs which allows restrict monitoring of the prescribed antibiotics has been suggested. In this report, the potential of mandatory antimicrobial stewardship programs on controlling antibiotic use which can lead to decrease in the rate of emerging superbugs will be

Antibiotic resistance has emerged as one of the greatest public health concerns of the 21st century. Nearly every type of bacteria has become stronger and less responsive to antibiotic treatment. This can eventually make it impossible to treat certain infections, leading to serious disability or death. The increasing prevalence of antibiotic-resistant bacterial infections can be attributed to overuse and over prescription. The uses of antibiotics in livestock are increasing resistance for animals and humans.

Dr. Martin Blaser, author of Missing Microbes: How the Overuse of Antibiotics is Fueling Our Modern Plagues, paints antibiotics as a negative force in the world that causes disease. Dr. Blaser has studied the role of bacteria in human disease for more than thirty years at Vanderbilt University, and has experience as the director of the Human Microbiome Project at New York University. He also works with the National Institute of Health on infectious diseases. Meanwhile, Dr. David Shlaes, author of Antibiotics: The Perfect Storm, focuses on the drugs’ ability to cure disease. Dr. Shlaes has worked for 30 years in anti-infective academia, industry, and consulting. He served as Professor of Medicine at Case Western Reserve University for five years, and then moved to industry, where he became vice president of Infectious Diseases at Wyeth Research. Later, he took a position as executive vice president of research and development at Idenix Pharmaceuticals in Cambridge, Massachusetts, and formed his own consulting company. He now works predominantly with biotech companies and venture capital firms in their evaluation of anti-infective companies. While they take different approaches, the two doctors concur that antibiotic resistance is a major problem and that society needs to find ways to slow it down. One way to slow down the spread of resistant bacteria is finding ways to ensure

Antibiotic-resistant microbes infect more than two million Americans and kill over 100,000 each year. These numbers will continue to grow unless we make a drastic effort to curtail them. The necessary response is threefold and includes legislation, awareness, and activism. I will address all of these.

Antibiotics have been taking over the United States. Antibiotics have become resistant. Americans can no longer not focus on this topic. It has taken over. The medical community has made the public aware of the causes and possible solutions of this health emergency, and its devastating impact..

According to Nathan Seppa, in "Doctors Enlisted to Turn the Tide on Antibiotic Resistance", "an overuse of antibiotics has spawned bacterial resistance to the drugs and threatend to erase decades of sucess." It is possible to contract a infection and have no cure. There is no need to worry about not having a cure. Seppa says, "many treatment centers are taking a surprisingly low-tech approach: They are changing the behavior of prescribing physicians." This course is called, " antimicrobial stewardship". Pharmaceutical companies will have to soon start making new forms of antibiotics.

According the World Health Organization (WHO), antibiotic resistance is one of the world’s greatest health threats to date (Haddox, 2013). In the article, The Health Threat of Antibiotic Resistance, Gail Haddox (2013) discusses the danger antibiotic resistance poses in today’s society and strategies to prevent the expansion of antibiotic resistance. In Europe alone, an estimated 25,000 deaths have been attributed to multi-resistant infections (Haddox, 2013). Common infections are now harder to treat due to the increased resistance to antibiotics across the world, in fact some are becoming untreatable. Antibiotics should be treated like oil, a non-renewable resource (Haddox, 2013).

The overuse of antibiotics has been a problem for well over a decade. This misuse leads to many nonvisible problems arising within the human population. As the use of antibiotics increases, the number of antibiotic resistant bacteria also increases. When bacteria become resistant to an antibiotic, another antibiotic must be used to try and kill it and the cycle becomes vicious. Michael Martin, Sapna Thottathil, and Thomas Newman stated that antimicrobial resistance is, “an increasingly serious threat to global public health that requires action across all government sectors and society” (2409).

The health issues that this article focuses on is antibiotic resistance. Antibiotic resistance is a major problem in the healthcare field because antibiotics are not being produced at the same rate as the bacteria are strengthening. The article explains how a new test can help physicians know when strong second line antibiotics are necessary. Without this test physicians will continue to automatically prescribe the strongest antibiotics to be sure